Kobayashi et al[11] showed that chemotherapy with panitumumab, a fully human IgG2 monoclonal antibody against epidermal growth factor receptor, is safe and effective in cancer patient with chronic kidney disease on HD. This evidence concerns the gene EGFR and cancer.